English Українська
  • Main
  • Useful links
  • Information for Contributors
  • About
  • Editorial board

  • Article
    Gubar I.V., Apykhtina O.L., Kaminsky R.F., Chaikovsky Yu.B., Yavorovsky O.P., Sokurenko L.M.

    ORGANOTOXIC EFFECT OF SINGLE INTRATRACHEAL ADMINISTRATION OF LEAD NANOPARTICLES OF DIFFERENT SIZES


    About the author: Gubar I.V., Apykhtina O.L., Kaminsky R.F., Chaikovsky Yu.B., Yavorovsky O.P., Sokurenko L.M.
    Heading EXPERIMENTAL MEDICINE
    Type of article Scentific article
    Annotation Cardiovasotoxic effect of a single intratracheal administration of lead nanoparticles of different sizes was studied in the experiment. Сolloidal solutions of lead sulfide (PbS in sodium polyphosphate) with an average size of 26–34 nm and 50–80 nm, and lead nitrate Pb(NO3)2 in ionic form which is well soluble in water were used. Toxic effects were assessed 12 days after exposure. Morphological changes were found in the myocardium and to a greater extent in the atria. Mild disorders, such as enlarged interstitial space and dystrophic changes of individual cardiomyocytes were found after administration of PbS26–34nm and Pb50–80nm nanoparticles. Thus, with intratracheal administration of lead, the toxic effect of nanoparticles PbS26–34nm and PbS50–80nm was manifested more compared with an effect caused by the action of the ionic form of lead Pb(NO3)2. The toxic effect of lead nanoparticles was mainly evident in the atrial myocardium cardiomyocytes, while the aortic wall remained almost unaffected. The most pronounced structural changes were observed in the lungs and bronchi, which may be due to the route of the toxicant administration.
    Tags lead, nanoparticles, intratracheal intoxication, morphological changes, myocardium, aorta, lungs
    Bibliography
    • Aleksijchuk VD, Sokurenko LM, Omelchuk ST. Peculiarities of lead sulfide and nitrate nanoparticles influence on organisms of experimental animals in different research periods and methods of its negative impact correction. World of medicine and biology. 2015; 4 (54): 97–101.
    • Bláhová L, Nováková Z, Večeřa Z, Vrlíková L, Dočekal B, Dumková J et.al. The effects of nano–sized PbO on biomarkers of membrane disruption and DNA damage in a sub–chronic inhalation study on mice. Nanotoxicology 2020; 14(2): 214–231. DOI: 10.1080/17435390.2019.1685696
    • Bostan NB, Rezaee R, Valokala MG, Tsarouhas K, Golokhvast K, Tsatsakis AM et.al. Cardiotoxicity of nanoparticles. Life Sciences. 2016; 165: 91–99. DOI: 10.1016/j.lfs.2016.09.017
    • Dumková J, Smutná T, Vrlíková L, Le Coustumer P, Večeřa Z, Dočekal B et.al. Sub–chronic inhalation of lead oxide nanoparticles revealed their broad distribution and tissue–specific subcellular localization in target organs. Part Fibre Toxicol. 2017; 14(1): 55. DOI: 10.1186/s12989–017–0236–y
    • Dumková J, Smutná T, Vrlíková L, Kotasová H, Dočekal B, Čapka L et.al. Variability in the Clearance of Lead Oxide Nanoparticles Is Associated with Alteration of Specific Membrane Transporters. ACS Nano 2020; 14(3): 3096–3120. https://doi.org/10.1021/acsnano.9b08143
    • Gubar IV, Lavrynenko VE, Chuchrai SM, Savosko SI, Sokurenko LM, Apykhtina OL et.al. Cardiovasotoxic effect of different sizes lead nanoparticles introduction. World of Medicine and Biology. 2020; 2 (72): 146–151. DOI 10.26724/2079–8334–2020–2–72–146–151.
    • Gubar IV, Sokurenko LM, Savosko SI, Apykhtina OL, Yavorоsky OP, Chaikovsky YuB Evaluation of protective effect of Thiocetam drug by morphological changes in the heart and vessels after administration of lead nanoparticles of various sizes (experimental study). Reports of Morphology. 2019; 25 (4): 5-19. DOI: 10.31393/morphology-journal-2019-25(4)-01
    • Khan I, Saeed K, Khan I. Nanoparticles: Properties, applications and toxicities. Arabian Journal of Chemistry, 2019; 12(7): 908–931. https://doi.org/10.1016/j.arabjc.2017.05.011
    • Khanna P, Ong C, Bay BH, Baeg GH. Nanotoxicity: an interplay of oxidative stress, inflammation and cell death. Nanomaterials (Basel, Switzerland) 2015; 5: 1163–1180. https://doi.org/10.3390/nano5031163
    • Lebedová J, Nováková Z, Večeřa Z, Buchtová M, Dumková J, Dočekal B et.al. Impact of acute and subchronic inhalation exposure to PbO nanoparticles on mice. Nanotoxicology. 2018; 12(4): 290–304. doi: 10.1080/17435390.2018.1438679. 
    • Li Q, Hu X, Bai Y, Alattar M, Ma D, Cao Y et.al. The oxidative damage and inflammatory response induced by lead sulfide nanoparticles in rat lung. Food Chem Toxicol. 2013; 60: 213–217. doi: 10.1016/j.fct.2013.07.046.
    • Oberbek P, Kozikowski P, Czarnecka K, Sobiech P, Jakubiak S, Jankowski T. Inhalation exposure to various nanoparticles in work environment – contextual information and results of measurements. J Nanopart Res. 2019; 21: 222. https://doi.org/10.1007/s11051–019–4651–x
    • Porcari A, Borsella E, Benighaus C, Grieger Kh, Isigonis P, Chakravarty S et.al. From risk perception to risk governance in nanotechnology: a multi–stakeholder study. J Nanopart Res 2019; 21: 245. https://doi.org/10.1007/s11051–019–4689–9
    • Warheit DB. Hazard and risk assessment strategies for nanoparticle exposures: how far have we come in the past 10 years? F1000Res. 2018; 7:376. https:// doi.org/10.12688/f1000research.12691.1.
    • Zhao L, Zhu Y, Chen Z, Xu H, Zhou J, Tang S et.al. Cardiopulmonary effects induced by occupational exposure to titanium dioxide nanoparticles. Nanotoxicology. 2018; 12(2):169–184
    Publication of the article «World of Medicine and Biology» №3(73), 2020 year, 168-175 pages, index UDK 616.12/.14–091.8:546.815/.819–022.513.2:57.084.1
    DOI 10.26724/2079-8334-2020-3-73-168-175